SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla wins Frost & Sullivan and TERI’s Sustainability 4.0 Award

13 Jan 2022 Evaluate

Cipla has been awarded winner as a “Challenger in Mega Large Business Pharma Sector” by Frost & Sullivan and TERI’s Sustainability 4.0 Awards. The award is a testimony to Cipla’s continuous efforts in the Environment, Social & Governance (ESG) space as a leader in the pharma industry. The company has been selected from a list of 50 reputed companies nominated for this award.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1231.55 2.65 (0.22%)
21-Apr-2026 12:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.20
Dr. Reddys Lab 1219.55
Cipla 1231.55
Zydus Lifesciences 928.40
Lupin 2322.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×